OSR Health (OSRH) Net Cash Flow (2022 - 2026)
OSR Health's (OSRH) quarterly Net Cash Flow came in at -$35853.3 in Q2 2026, up 70.01% year-over-year from -$21088.9 in Q2 2025, and up 25.58% quarter-over-quarter from -$48177.7 in Q1 2026.
Powered by 
Analysis
OSR Health (OSRH) Net Cash Flow (2022 - 2026) Analysis & Trends
OSR Health has disclosed Net Cash Flow across 5 years of filings, most recently posting -$35853.3 for Q2 2026.
- In Q2 2026, Net Cash Flow rose 70.01% year-over-year to -$35853.3; the TTM figure through Jun 2026 stood at $161763.0 (down 83.84% YoY), while the FY2025 annual figure was $1.4 million, up 964.95% from the prior year.
- Net Cash Flow came in at -$35853.3 for Q2 2026 at OSR Health, up from -$48177.7 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $1.3 million in Q1 2025 to a low of -$431928.0 in Q4 2025.
- Average Net Cash Flow over 5 years is $67683.1, with a median of -$5563.0 recorded in 2024.
- The largest YoY upside for Net Cash Flow was 22945.63% in 2025 against a maximum downside of 2118.83% in 2025.
- Over 5 years, Net Cash Flow stood at $55666.0 in 2022, then slumped by 176.41% to -$42536.0 in 2023, then slipped by 11.26% to -$47326.0 in 2024, then slumped by 812.67% to -$431928.0 in 2025, then jumped by 91.7% to -$35853.3 in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$35853.3 in Q2 2026, -$48177.7 in Q1 2026, and -$431928.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -4.43 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 652.90 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | -504.30 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -183.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | -496,000.00 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -170.75 Mn |
| 10 | OSR Health | 6.59 Mn | 4.94 Mn | 86,605.00 | -35,853.27 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35,853.27 |
| Mar 31, 2026 | -48,177.73 |
| Dec 31, 2025 | -431,928.00 |
| Sep 30, 2025 | 677,722.00 |
| Jun 30, 2025 | -119,550.37 |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | -47,326.00 |
| Sep 30, 2024 | -103,252.00 |
| Jun 30, 2024 | -5,388.00 |
| Mar 31, 2024 | -5,563.00 |
| Dec 31, 2023 | -42,536.00 |
| Sep 30, 2023 | 56,774.00 |
| Jun 30, 2023 | -347,621.00 |
| Mar 31, 2023 | 224,301.00 |
| Dec 31, 2022 | 55,666.00 |
| Sep 30, 2022 | -5,339.00 |
| Jun 30, 2022 | 57,782.00 |